Trinity Biotech (TRIB) Debt to Equity (2016 - 2020)
Trinity Biotech (TRIB) has disclosed Debt to Equity for 5 consecutive years, with -$0.01 as the latest value for Q4 2020.
- Quarterly Debt to Equity fell 100.08% to -$0.01 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$0.01 through Dec 2020, down 100.08% year-over-year, with the annual reading at -$0.01 for FY2020, 100.08% down from the prior year.
- Debt to Equity hit -$0.01 in Q4 2020 for Trinity Biotech, down from $17.4 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $17.4 in Q4 2019 to a low of -$0.01 in Q4 2020.
- Historically, Debt to Equity has averaged $4.3 across 5 years, with a median of $1.43 in 2017.
- Biggest five-year swings in Debt to Equity: surged 842.07% in 2019 and later tumbled 100.08% in 2020.
- Year by year, Debt to Equity stood at $0.85 in 2016, then soared by 68.08% to $1.43 in 2017, then rose by 29.57% to $1.85 in 2018, then soared by 842.07% to $17.4 in 2019, then tumbled by 100.08% to -$0.01 in 2020.
- Business Quant data shows Debt to Equity for TRIB at -$0.01 in Q4 2020, $17.4 in Q4 2019, and $1.85 in Q4 2018.